N-Glycosylation can selectively block or foster different receptor-ligand binding modes
Jazyk angličtina Země Velká Británie, Anglie Médium electronic
Typ dokumentu časopisecké články, práce podpořená grantem
PubMed
33664400
PubMed Central
PMC7933184
DOI
10.1038/s41598-021-84569-z
PII: 10.1038/s41598-021-84569-z
Knihovny.cz E-zdroje
- MeSH
- antigeny CD44 genetika ultrastruktura MeSH
- buněčná adheze genetika MeSH
- glykosylace MeSH
- konformace proteinů * MeSH
- kyselina hyaluronová genetika MeSH
- lidé MeSH
- magnetická rezonanční spektroskopie MeSH
- polysacharidy genetika MeSH
- receptory buněčného povrchu genetika MeSH
- vazba proteinů genetika MeSH
- vazebná místa genetika MeSH
- Check Tag
- lidé MeSH
- Publikační typ
- časopisecké články MeSH
- práce podpořená grantem MeSH
- Názvy látek
- antigeny CD44 MeSH
- kyselina hyaluronová MeSH
- polysacharidy MeSH
- receptory buněčného povrchu MeSH
While DNA encodes protein structure, glycans provide a complementary layer of information to protein function. As a prime example of the significance of glycans, the ability of the cell surface receptor CD44 to bind its ligand, hyaluronan, is modulated by N-glycosylation. However, the details of this modulation remain unclear. Based on atomistic simulations and NMR, we provide evidence that CD44 has multiple distinct binding sites for hyaluronan, and that N-glycosylation modulates their respective roles. We find that non-glycosylated CD44 favors the canonical sub-micromolar binding site, while glycosylated CD44 binds hyaluronan with an entirely different micromolar binding site. Our findings show (for the first time) how glycosylation can alter receptor affinity by shielding specific regions of the host protein, thereby promoting weaker binding modes. The mechanism revealed in this work emphasizes the importance of glycosylation in protein function and poses a challenge for protein structure determination where glycosylation is usually neglected.
Computational Physics Laboratory Tampere University PO Box 692 33014 Tampere Finland
Department of Physics University of Helsinki P O Box 64 00014 Helsinki Finland
Zobrazit více v PubMed
Corfield AP, Berry M. Glycan variation and evolution in the eukaryotes. Trends Biochem. Sci. 2015;40:351–359. doi: 10.1016/j.tibs.2015.04.004. PubMed DOI
Apweiler R, Hermjakob H, Sharon N. On the frequency of protein glycosylation, as deduced from analysis of the SWISS-PROT database1. Biochim. Biophys. Acta (BBA)-Gen. Subj. 1999;1473:4–8. doi: 10.1016/s0304-4165(99)00165-8. PubMed DOI
Halder S, Surolia A, Mukhopadhyay C. Dynamics simulation of soybean agglutinin (SBA) dimer reveals the impact of glycosylation on its enhanced structural stability. Carbohydr. Res. 2016;428:8–17. doi: 10.1016/j.carres.2016.04.009. PubMed DOI
Huang X, et al. Glycosylation affects both the three-dimensional structure and antibody binding properties of the HIV-1IIIB GP120 peptide RP135. Biochemistry. 1997;36:10846–10856. doi: 10.1021/bi9703655. PubMed DOI
Arshad N, Ballal S, Visweswariah SS. Site-specific N-linked glycosylation of receptor guanylyl cyclase C regulates ligand binding, ligand-mediated activation and interaction with vesicular integral membrane protein 36, VIP36. J. Biol. Chem. 2013;288:3907–3917. doi: 10.1074/jbc.M112.413906. PubMed DOI PMC
Lowery JW, Amich JM, Andonian A, Rosen V. N-linked glycosylation of the bone morphogenetic protein receptor type 2 (BMPR2) enhances ligand binding. Cell. Mol. Life Sci. 2014;71:3165–3172. doi: 10.1007/s00018-013-1541-8. PubMed DOI PMC
Moremen KW, Tiemeyer M, Nairn AV. Vertebrate protein glycosylation: diversity, synthesis and function. Nat. Rev. Mol. Cell Biol. 2012;13:448. doi: 10.1038/nrm3383. PubMed DOI PMC
Kaszuba, K. et al. N-Glycosylation as determinant of epidermal growth factor receptor conformation in membranes. Proc. Natl. Acad. Sci.201503262, 10.1073/pnas.1503262112 (2015). PubMed PMC
Lesley J, English N, Perschl A, Gregoroff J, Hyman R. Variant cell lines selected for alterations in the function of the hyaluronan receptor CD44 show differences in glycosylation. J. Exp. Med. 1995;182:431–437. doi: 10.1084/jem.182.2.431. PubMed DOI PMC
Lee HS, Qi Y, Im W. Effects of N-glycosylation on protein conformation and dynamics: Protein Data Bank analysis and molecular dynamics simulation study. Sci. Rep. 2015;5:8926. doi: 10.1038/srep08926. PubMed DOI PMC
Liwosz A, Lei T, Kukuruzinska MA. N-glycosylation affects the molecular organization and stability of E-cadherin junctions. J. Biol. Chem. 2006;281:23138–23149. doi: 10.1074/jbc.m512621200. PubMed DOI
Van Kooyk Y, Rabinovich GA. Protein-glycan interactions in the control of innate and adaptive immune responses. Nat. Immunol. 2008;9:593. doi: 10.1038/ni.f.203. PubMed DOI
van Oosten AS, Janmey PA. Extremely charged and incredibly soft: Physical characterization of the pericellular matrix. Biophys. J . 2013;104:961. doi: 10.1016/j.bpj.2013.01.035. PubMed DOI PMC
Vuorio J, Vattulainen I, Martinez-Seara H. Atomistic fingerprint of hyaluronan-CD44 binding. PLoS Comput. Biol. 2017;13:e1005663. doi: 10.1371/journal.pcbi.1005663. PubMed DOI PMC
Rudy W, et al. The two major CD44 proteins expressed on a metastatic rat tumor cell line are derived from different splice variants: each one individually suffices to confer metastatic behavior. Cancer Res. 1993;53:1262–1268. PubMed
Skelton TP, Zeng C, Nocks A, Stamenkovic I. Glycosylation provides both stimulatory and inhibitory effects on cell surface and soluble CD44 binding to hyaluronan. J. Cell Biol. 1998;140:431–446. doi: 10.1083/jcb.140.2.431. PubMed DOI PMC
Katoh S, Zheng Z, Oritani K, Shimozato T, Kincade PW. Glycosylation of CD44 negatively regulates its recognition of hyaluronan. J. Exp. Med. 1995;182:419–429. doi: 10.1084/jem.182.2.419. PubMed DOI PMC
Zheng Z, Cummings RD, Pummill PE, Kincade PW. Growth as a solid tumor or reduced glucose concentrations in culture reversibly induce CD44-mediated hyaluronan recognition by Chinese hamster ovary cells. J. Clin. Investig. 1997;100:1217. doi: 10.1172/jci119635. PubMed DOI PMC
English NM, Lesley JF, Hyman R. Site-specific de-N-glycosylation of CD44 can activate hyaluronan binding, and CD44 activation states show distinct threshold densities for hyaluronan binding. Cancer Res. 1998;58:3736–3742. PubMed
Aruffo A, Stamenkovic I, Melnick M, Underhill CB, Seed B. CD44 is the principal cell surface receptor for hyaluronate. Cell. 1990;61:1303–1313. doi: 10.1016/0092-8674(90)90694-a. PubMed DOI
Toole BP. Hyaluronan: from extracellular glue to pericellular cue. Nat. Rev. Cancer. 2004;4:528–539. doi: 10.1038/nrc1391. PubMed DOI
Ponta H, Sherman L, Herrlich PA. CD44: from adhesion molecules to signalling regulators. Nat. Rev. Mol. Cell Biol. 2003;4:33–45. doi: 10.1038/nrm1004. PubMed DOI
Wolf KJ, Kumar S. Hyaluronic acid: Incorporating the bio into the material. ACS Biomater. Sci. Eng. 2019;5:3753–3765. doi: 10.1021/acsbiomaterials.8b01268. PubMed DOI PMC
Teriete P, et al. Structure of the regulatory hyaluronan binding domain in the inflammatory leukocyte homing receptor CD44. Mol. Cell. 2004;13:483–496. doi: 10.1016/s1097-2765(04)00080-2. PubMed DOI
Banerji S, et al. Structures of the Cd44-hyaluronan complex provide insight into a fundamental carbohydrate-protein interaction. Nat. Struct. Mol. Biol. 2007;14:234–239. doi: 10.1038/nsmb1201. PubMed DOI
Han H, et al. Comprehensive characterization of the N-glycosylation status of CD44s by use of multiple mass spectrometry-based techniques. Anal. Bioanal. Chem. 2012;404:373–388. doi: 10.1007/s00216-012-6167-4. PubMed DOI
Katoh S, et al. A crucial role of sialidase Neu1 in hyaluronan receptor function of CD44 in T helper type 2-mediated airway inflammation of murine acute asthmatic model. Clin. Exp. Immunol. 2010;161:233–241. doi: 10.1111/j.1365-2249.2010.04165.x. PubMed DOI PMC
Faller CE, Guvench O. Terminal sialic acids on CD44 N-glycans can block hyaluronan binding by forming competing intramolecular contacts with arginine sidechains. Proteins Struct. Funct. Bioinf. 2014;82:3079–3089. doi: 10.1002/prot.24668. PubMed DOI PMC
Takeda M, et al. Hyaluronan recognition mode of CD44 revealed by cross-saturation and chemical shift perturbation experiments. J. Biol. Chem. 2003;278:43550–43555. doi: 10.1074/jbc.m308199200. PubMed DOI
Liu L-K, Finzel BC. Fragment-based identification of an inducible binding site on cell surface receptor CD44 for the design of protein-carbohydrate interaction inhibitors. J. Med. Chem. 2014;57:2714–2725. doi: 10.1021/jm5000276. PubMed DOI
Jamison FW, II, Foster TJ, Barker JA, Hills RD, Jr, Guvench O. Mechanism of binding site conformational switching in the CD44-hyaluronan protein-carbohydrate binding interaction. J. Mol. Biol. 2011;406:631–647. doi: 10.1016/j.jmb.2010.12.040. PubMed DOI
Favreau AJ, Faller CE, Guvench O. CD44 receptor unfolding enhances binding by freeing basic amino acids to contact carbohydrate ligand. Biophys. J . 2013;105:1217–1226. doi: 10.1016/j.bpj.2013.07.041. PubMed DOI PMC
Škerlová J, et al. Molecular mechanism for the action of the anti-CD44 monoclonal antibody MEM-85. J. Struct. Biol. 2015;191:214–223. doi: 10.1016/j.jsb.2015.06.005. PubMed DOI
Bajorath J, Greenfield B, Munro SB, Day AJ, Aruffo A. Identification of CD44 residues important for hyaluronan binding and delineation of the binding site. J. Biol. Chem. 1998;273:338–343. doi: 10.1074/jbc.273.1.338. PubMed DOI
Sandmaier BM, Storb R, Bennett KL, Appelbaum FR, Santos EB. Epitope specificity of CD44 for monoclonal antibody-dependent facilitation of marrow engraftment in a canine model. Blood. 1998;91:3494–3502. doi: 10.1182/blood.v91.9.3494.3494_3494_3502. PubMed DOI
Varki A, et al. Symbol nomenclature for graphical representations of glycans. Glycobiology. 2015;25:1323–1324. doi: 10.1093/glycob/cwv091. PubMed DOI PMC
van Bueren, A. L. & Boraston, A. B. Binding sub-site dissection of a carbohydrate-binding module reveals the contribution of entropy to oligosaccharide recognition at “non-primary” binding subsites. J. Mol. Biol.340, 869–879. 10.1016/j.jmb.2004.05.038 (2004). PubMed
Katoh S, et al. Cutting edge: an inducible sialidase regulates the hyaluronic acid binding ability of CD44-bearing human monocytes. J. Immunol. 1999;162:5058–5061. PubMed
DeGrendele HC, Estess P, Picker LJ, Siegelman MH. CD44 and its ligand hyaluronate mediate rolling under physiologic flow: a novel lymphocyte-endothelial cell primary adhesion pathway. J. Exp. Med. 1996;183:1119–1130. doi: 10.1084/jem.183.3.1119. PubMed DOI PMC
DeGrendele HC, Estess P, Siegelman MH. Requirement for CD44 in activated T cell extravasation into an inflammatory site. Science. 1997;278:672–675. doi: 10.1126/science.278.5338.672. PubMed DOI
Polley A, et al. Glycosylation and lipids working in concert direct CD2 ectodomain orientation and presentation. J. Phys. Chem. Lett. 2017;8:1060–1066. doi: 10.1021/acs.jpclett.6b02824. PubMed DOI PMC
Peiris D, et al. Cellular glycosylation affects Herceptin binding and sensitivity of breast cancer cells to doxorubicin and growth factors. Sci. Rep. 2017;7:43006. doi: 10.1038/srep43006. PubMed DOI PMC
Rudd PM, Wormald MR, Dwek RA. Sugar-mediated ligand-receptor interactions in the immune system. Trends Biotechnol. 2004;22:524–530. doi: 10.1016/j.tibtech.2004.07.012. PubMed DOI
Berman HM, et al. The protein data bank. Nucleic Acids Res. 2000;28:235–242. doi: 10.1201/9780203911327.ch14. PubMed DOI PMC
Danne R, et al. doGlycans-tools for preparing carbohydrate structures for atomistic simulations of glycoproteins, glycolipids, and carbohydrate polymers for GROMACS. J. Chem. Inf. Model. 2017;57:2401–2406. doi: 10.1021/acs.jcim.7b00237. PubMed DOI PMC
Humphrey W, Dalke A, Schulten K. VMD: Visual molecular dynamics. J. Mol. Graph. 1996;14:33–38. doi: 10.1016/0263-7855(96)00018-5. PubMed DOI
Dang LX. Development of nonadditive intermolecular potentials using molecular dynamics: solvation of Li+ and F- ions in polarizable water. J. Chem. Phys. 1992;96:6970–6977. doi: 10.1063/1.462555. DOI
Jorgensen WL, Chandrasekhar J, Madura JD, Impey RW, Klein ML. Comparison of simple potential functions for simulating liquid water. J. Chem. Phys. 1983;79:926–935. doi: 10.1063/1.445869. DOI
Abraham MJ, et al. GROMACS: High performance molecular simulations through multi-level parallelism from laptops to supercomputers. SoftwareX. 2015;1:19–25. doi: 10.1016/j.softx.2015.06.001. DOI
Hess, B., Bekker, H., Berendsen, H. J. C. & Fraaije, J. G. E. M. LINCS: a linear constraint solver for molecular simulations. J. Comput. Chem.18, 1463–1472. https://doi.org/10.1002/(sici)1096-987x(199709)18:12%3c1463::aid-jcc4%3e3.0.co;2-h (1997).
Darden T, York D, Pedersen L. Particle mesh Ewald: An N log (N) method for Ewald sums in large systems. J. Chem. Phys. 1993;98:10089–10092. doi: 10.1063/1.464397. DOI
Bussi G, Donadio D, Parrinello M. Canonical sampling through velocity rescaling. J. Chem. Phys. 2007;126:4101. doi: 10.1063/1.2408420. PubMed DOI
Parrinello M, Rahman A. Polymorphic transitions in single crystals: A new molecular dynamics method. J. Appl. Phys. 1981;52:7182–7190. doi: 10.1063/1.328693. DOI
Jo S, Kim T, Iyer VG, Im W. CHARMM-GUI: A web-based graphical user interface for CHARMM. J. Comput. Chem. 2008;29:1859–1865. doi: 10.1002/jcc.20945. PubMed DOI
Hess B, Kutzner C, van der Spoel D, Lindahl E. GROMACS 4: Algorithms for highly efficient, load-balanced, and scalable molecular simulation. J. Chem. Theory Comput. 2008;4:435–447. doi: 10.1021/ct700301q. PubMed DOI
Pronk, S. et al. GROMACS 4.5: a high-throughput and highly parallel open source molecular simulation toolkit. Bioinformaticsbtt055, 10.1093/bioinformatics/btt055 (2013). PubMed PMC
Veverka V, et al. Structural characterization of the interaction of mTOR with phosphatidic acid and a novel class of inhibitor: compelling evidence for a central role of the FRB domain in small molecule-mediated regulation of mTOR. Oncogene. 2008;27:585. doi: 10.1038/sj.onc.1210693. PubMed DOI